Evidence map›Paper›PMID 42911546›Full record

ReviewClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico2026

Recommendations from the Geriatric Oncology Working Group of the Spanish Society of Radiation Oncology for the treatment of elderly patients with radiotherapy.

Pilar Mª Samper Ots, Elisabet Gonzalez Del Portillo, Andrea Bobo Jaureguizar, Carolina de la Pinta, Sara Pedraza Fernández, Vanessa Gabriela Jerviz Guía, Luis Alberto Pérez Romasanta

Abstract readReview
PubMed Publisher
In one paragraph

Review in Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Pilar Mª Samper OtsRadiation Oncology, Hospital Universitario Rey Juan Carlos, Móstoles, Spain. pilar.samper@hospitalreyjuancarlos.es.ORCID http://orcid.org/0000-0002-2020-6431
Elisabet Gonzalez Del PortilloRadiation Oncology, Hospital Universitario Rey Juan Carlos, Móstoles, Spain.ORCID http://orcid.org/0000-0002-0758-8156
Andrea Bobo JaureguizarFEA Oncología Radioterapica Hospital Ruber Internacional, Madrid, Spain.ORCID http://orcid.org/0000-0002-5627-7434
Carolina de la PintaFEA de Oncología Radioterápica, IP Grupo de Biomarcadores y Dianas Terapéuticas, Hospital Universitario Ramón y Cajal, IRYCIS, Madrid, Spain.ORCID http://orcid.org/0000-0002-5425-3471
Sara Pedraza FernándezFEA Oncología Radioterápica Hospital Universitario 12 de Octubre, Madrid, Spain.ORCID http://orcid.org/0000-0001-9387-1937
Vanessa Gabriela Jerviz GuíaFEA de Oncología Radioterápica, Hospital Universitario Clínico San Cecilio, Granada, Spain.ORCID http://orcid.org/0009-0009-8647-4955
Luis Alberto Pérez RomasantaOncología Radioterápica, Complejo Asistencial Universitario de Salamanca, IBSAL, Universidad de Salamanca, Salamanca, Spain.ORCID http://orcid.org/0000-0001-8117-5459

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Population ageing is increasing the number of older adults diagnosed with cancer, many of whom require radiotherapy (RT). This population is highly heterogeneous and frequently underrepresented in clinical trials, making treatment decisions particularly challenging. This review, developed by the Geriatric Oncology Working Group of the Spanish Society of Radiation Oncology (SEOR), provides practical recommendations for optimizing RT in elderly patients with cancer based on current evidence and expert consensus. Comprehensive geriatric assessment (CGA) is highlighted as the cornerstone of individualized care, enabling evaluation of functional status, comorbidities, cognition, nutritional status, and social factors. A two-step approach, consisting of an initial screening followed by CGA when indicated, is recommended to identify vulnerable patients and support clinical decision-making. Integration of geriatric assessment allows classification of patients as robust, vulnerable, or frail, facilitating personalized treatment strategies. Chronological age alone is not a reliable predictor of RT tolerance, whereas functional reserve and frailty are critical determinants of outcomes. Advanced RT techniques and hypofractionated schedules may improve treatment accessibility and reduce patient burden without compromising efficacy. Adaptation of treatment, including radiation dose, target volumes, and combined therapies, should be tailored to individual patient characteristics. Supportive interventions such as nutritional optimization, physical exercise, and symptom management are essential to improve treatment tolerance and quality of life. Multidisciplinary care and the incorporation of patient-reported outcomes further contribute to patient-centered management. Overall, RT in older patients should be individualized according to geriatric assessment rather than age alone, and CGA-driven strategies, personalized treatment adaptation, and integrated supportive care are key to optimizing outcomes. Further research focusing on frail older populations is warranted.

Indexed as

Elderly patientsFrailtyGeriatric assessmentHypofractionationMultidisciplinary careRadiotherapyToxicity

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.